Superficial mycoses: treatment with a new, broad-spectrum antifungal agent: 1% clotrimazole solution.
A 1% clotrimazole solution was used as an antifungal for Tinea versicolor, Cutaneous Candidiasis and Dermatophytosis. All studies were double-blind and controlled, active vs vehicle. The final evaluation was made at a two-week follow-up after the treatment was stopped, which for most of the clinical conditions studied, was 28 days. The 1% clotrimazole solution was found to be effective with no local irritation noted.
D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003022:Clotrimazole / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D014005:Tinea / Q000188:drug therapy; D014008:Tinea Pedis / Q000188:drug therapy; D014010:Tinea Versicolor / Q000188:drug therapy
D007093:Imidazoles; D003022:Clotrimazole